Oramed Pharmaceuticals (ORMP) - Stock price history

Stock price history of Oramed Pharmaceuticals from 2007 to 2026

Annual Stock Price Performance

Year	Performance
2026	82.81%
2025	18.26%
2024	-1.22%
2023	-81.37%
2022	-13.39%
2021	228.28%
2020	-14.17%
2019	53.27%
2018	-67.18%
2017	41.07%
2016	-27.92%
2015	71.00%
2014	-74.95%
2013	278.19%
2012	22.22%
2011	-17.65%
2010	-25.00%
2009	12.50%
2008	25.81%
2007	-60.61%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Novo Nordisk NVO	£35.65	3.71%	🇩🇰 Denmark
Sanofi SNY	£33.72	0.72%	🇫🇷 France
Ultragenyx Pharmaceutical RARE	£19.39	2.88%	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	£1.71	0.86%	🇺🇸 USA
Compugen CGEN	£2.10	10.81%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Oramed Pharmaceuticals (ORMP)